RE:70% of TLT patients are CIS...Wildbird1 ... Great post and link that confirms the heavy lifting TLT has done so far and how difficult it is to tackle those CIS cases.
You provided a perspective that will justify the interest of a big pharma, without a doubt, given the challenge CIS cases present.
Again, excellent post. The link is really worth consulting to understand the outstanding job Theralase has done so far.
Hold on to your shares. Recognition (and so validation) will come. It's just a question of time. TLT is doing the right things, in the right order, not cutting corners and respecting the very conservative attitude on the e urology industry. They don't like splash. They want data. Convincing data. Then, they will adopt.